Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

[Expressions and clinical significance of OX40 and OX40L in peripheral blood of patients with primary Sjogren's syndrome].

Zhu R, Jiang J, Wang T, Xu T, Wu M, Liu C, Zhang X.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013 Aug;29(8):862-5. Chinese.

PMID:
23948416
2.

[Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].

Li XM, Li XP, Qian L, Wang GS, Zhang H, Zhei ZM, Li Q, Chen K, Wang XQ, Wang YP.

Zhonghua Yi Xue Za Zhi. 2007 Apr 17;87(15):1034-6. Chinese.

PMID:
17672966
3.

OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.

Farres MN, Al-Zifzaf DS, Aly AA, Abd Raboh NM.

Ann Saudi Med. 2011 Jan-Feb;31(1):29-34. doi: 10.4103/0256-4947.75775.

4.

Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis.

Laustsen JK, Rasmussen TK, Stengaard-Pedersen K, Hørslev-Petersen K, Hetland ML, Østergaard M, Junker P, Hvid M, Deleuran B.

Arthritis Res Ther. 2014 Oct 30;16(5):474. doi: 10.1186/s13075-014-0474-4.

5.

OX40 mRNA in peripheral blood as a biomarker of acute renal allograft rejection.

Wang YL, Fu YX, Zhu ZJ, Wang H, Shen ZY.

Chin Med J (Engl). 2012 Nov;125(21):3786-90.

PMID:
23106874
6.

B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.

Lin W, Jin L, Chen H, Wu Q, Fei Y, Zheng W, Wang Q, Li P, Li Y, Zhang W, Zhao Y, Zeng X, Zhang F.

Arthritis Res Ther. 2014 May 29;16(3):R118. doi: 10.1186/ar4571.

7.

Simvastatin reduces OX40 and OX40 ligand expression in human peripheral blood mononuclear cells and in patients with atherosclerotic cerebral infarction.

Liu B, Yu G, Yang Z, Sun L, Song R, Liu F, Xin Y, Zhang L.

J Int Med Res. 2009 May-Jun;37(3):601-10.

PMID:
19589242
8.

miR-146a and miR-155 expression in PBMCs from patients with Sjögren's syndrome.

Shi H, Zheng LY, Zhang P, Yu CQ.

J Oral Pathol Med. 2014 Nov;43(10):792-7. doi: 10.1111/jop.12187. Epub 2014 Jun 14.

PMID:
24931100
9.

Activity of T-helper cells in patients with primary Sjogren's syndrome.

Sudzius G, Mieliauskaite D, Butrimiene I, Siaurys A, Mackiewicz Z, Dumalakiene I.

In Vivo. 2013 Mar-Apr;27(2):263-8.

PMID:
23422488
10.

T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.

Li X, Li X, Qian L, Wang G, Zhang H, Wang X, Chen K, Zhai Z, Li Q, Wang Y, Harris DC.

J Rheumatol. 2007 Dec;34(12):2438-45. Epub 2007 Nov 15.

PMID:
18050367
11.

Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.

Willeke P, Gaubitz M, Schotte H, Maaser C, Domschke W, Schlüter B, Becker H.

Arthritis Res Ther. 2007;9(2):R43.

12.

The expression of P2X7 receptors on peripheral blood mononuclear cells in patients with primary Sjögren's syndrome and its correlation with anxiety and depression.

Xie B, Chen Y, Zhang S, Wu X, Zhang Z, Peng Y, Huang X.

Clin Exp Rheumatol. 2014 May-Jun;32(3):354-60. Epub 2014 Jan 30.

PMID:
24480517
13.

B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.

Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X.

Scand J Immunol. 2008 Feb;67(2):185-92. doi: 10.1111/j.1365-3083.2007.02049.x.

14.

Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren's syndrome.

Zheng L, Zhang Z, Yu C, Yang C.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Jun;109(6):844-50. doi: 10.1016/j.tripleo.2010.01.006.

PMID:
20399690
15.

Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.

Ukyo N, Hori T, Yanagita S, Ishikawa T, Uchiyama T.

Immunology. 2003 Jun;109(2):226-31.

16.

Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.

Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X.

Ann Rheum Dis. 2007 Jun;66(6):790-7. Epub 2006 Dec 21.

17.

IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.

Alunno A, Bistoni O, Bartoloni Bocci E, Caterbi S, Bigerna B, Pucciarini A, Tabarrini A, Mannucci R, Beghelli D, Falini B, Gerli R.

Reumatismo. 2013 Oct 31;65(4):192-8. doi: 10.4081/reumatismo.2013.192.

PMID:
24192564
18.

Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjogren's syndrome.

Liu MF, Lin LH, Weng CT, Weng MY.

Lupus. 2008 Jan;17(1):34-9.

PMID:
18089681
19.

OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity.

Ilves T, Harvima IT.

J Eur Acad Dermatol Venereol. 2013 Feb;27(2):e197-205. doi: 10.1111/j.1468-3083.2012.04587.x. Epub 2012 May 31.

PMID:
22646697
20.

Expression of interferon regulatory factor 1, 3, and 7 in primary Sjögren syndrome.

Zheng L, Yu C, Zhang Z, Yang C, Cai X.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 May;107(5):661-8. doi: 10.1016/j.tripleo.2009.01.039.

PMID:
19426920

Supplemental Content

Support Center